Insights

Required Coverage for PANDAS and PANS


On April 27, 2021, Commissioner of Insurance Anderson issued Bulletin 2021-06, informing insurers of the requirement to cover treatment for pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS) and pediatric acute-onset neuropsychiatric syndrome (PANS).

The division expects insurers to notify network providers and covered members of the mandated coverage, to update their administrative processes to enable members to access treatment for PANDAS and PANS, and to identify providers within their networks who can provide PANDAS and PANS services.

This insurance mandate will apply to insured health benefits that are issued or renewed on or after January 1, 2022. Although this mandate applies to insurers, employers should familiarize themselves with it in the event that a participant has questions about this coverage.

Bulleting 2021-06 »